Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers ugly split with Wegovy maker weighs on the telehealth companys future

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership…

Hims & Hers ugly split with Wegovy maker weighs on the telehealth companys future

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership…

Hims & Hers (HIMS) Rallies 11.76% as CEO Not Backing Down After Novo Nordisk Spat

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 10 Stocks Delivering Eye-Popping Gains. Hims & Hers rebounded by…

Novo Nordisk partners with WeightWatchers after Hims & Hers fallout

The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging…

Robinhood-Gold-Macherin wird CPO bei Hims

Aktie springt um über 20?%: Dheerja Kaur wird erste Chief Product Officer bei Hims Ex-Robinhood-Managerin soll Plattformwachstum mit KI,…

Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy®- Hagens Berman

/PRNewswire/ -- On June 25, 2025, two securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE:…

Jim Cramer on Hims & Hers: “You Gotta Generate Some Discipline Here”

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 14 stocks Jim Cramer recently shared insights on. Discussing the…

HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims &…

Why Is Hims & Hers Health (HIMS) Stock Soaring Today

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.1% in the afternoon session after the companys CEO stated…

HIMS BREAKING NEWS: A Class Action Lawsuit has been filed against Hims & Hers Health, Inc. -- Investors are Notified to Contact BFA Law to Potentially Recover Investment Losses

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers…

Novo Nordisk ends Hims & Hers deal over Wegovy knockoffs

Novo Nordisk cut ties with Hims & Hers, accusing the telehealth firm of promoting Wegovy copycat versions of the weight-loss…

Whats Going On With Hims & Hers Health Stock Today? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Thursday. The stock appears to be bouncing back a…

Hims & Hers Health (NYSE:HIMS) Faces Class Action After Partnership Termination With Novo Nordisk

Hims & Hers Health (NYSE:HIMS) has experienced a tumultuous quarter, marked by Novo Nordisks termination of their collaboration after allegations…

WeightWatchers Customers Now Have Access to Wegovy at a Cheaper Price

Novo Nordisk A/S added a deal with WeightWatchers to boost access to its Wegovy obesity drug, just days after axing…

Law Offices of Frank R. Cruz Encourages Hims & Hers Health, Inc. (HIMS) Investors To Inquire About Securities Fraud Class Action

Law Offices of Frank R. Cruz Encourages Hims & Hers Health, Inc. (HIMS) Investors To Inquire About Securities Fraud Class…

Hims & Hers Health (HIMS) Loses 22.4% in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Hims & Hers Health (HIMS) as it is technically in oversold territory…

Hims & Hers appoints former Robinhood exec Dheerja Kaur as first CPO By Investing.com

Hims & Hers appoints former Robinhood exec Dheerja Kaur as first CPO…

Rosen Law Firm Urges Hims & Hers Health, Inc. (NYSE: HIMS) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of…

Hims & Hers Health (HIMS) Loses 22.4% in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Hims & Hers Health (HIMS) as it is technically in oversold territory…

Hims & Hers Health (HIMS) Loses 22.4% in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Hims & Hers Health (HIMS) as it is technically in oversold territory…

Welcoming Dheerja Kaur, our first Chief Product Officer

Hims & Hers welcomes Dheerja Kaur as its first Chief Product Officer to lead the next generation of personalized healthcare…

Hims & Hers: Die Anti-Establishment-Aktie mit Kultpotenzial!

In den letzten Jahren war Hims & Hers geradezu ein Paradebeispiel für eine "Buy the Dip"-Aktie: Auf jeden Rücksetzer folgte früher…

Hims & Hers will trotz Trennung von Novo Nordisk weiter günstige Abnehmspritzen verkaufen

Hims & Hers Health will trotz des überraschenden Ausstiegs von Novo Nordisk an seinem umstrittenen Geschäft mit günstigen Semaglutid-Injektionen festhalten.…

Why Hims & Hers stock may be stronger after Novo Nordisk breakup

An analyst said that Hims’ (HIMS) breakup with Novo Nordisk (NVO) isn’t as bad as it appears.…

Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over “Deceptive” Marketing of Wegovy– Hagens Berman

HIMS Investors with Losses Encouraged to Contact Hagens Berman...…

Hims & Hers Health, Inc.: Please contact the Portnoy Law Firm to recover your losses; August 25, 2025 Deadline to file Lead Plaintiff Motion

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June…

HIMS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Hims & Hers Class Action Lawsuit

SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or…

HIMS & HERS HEALTH, INC. (NYSE: HIMS) INVESTOR ALERT: Investors With Large Losses in Hims & Hers Health, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

HIMS & HERS HEALTH, INC. (NYSE: HIMS) INVESTOR ALERT: Investors With Large Losses in Hims & Hers Health, Inc. Should…

Marketing Daily - Top of the News: Novo Nordisk, Hims & Hers Deal Ends

The pharma company in April said it would offer Wegovy through several telehealth companies such as Hims & Hers to…

Hims & Hers Health, Inc. (HIMS) Shares Crash After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy, Faces Investor Scrutiny- Hagens Berman

SAN FRANCISCO, June 25, 2025 /PRNewswire/ -- On June 23, 2025 investors in Hims & Hers Health, Inc. (NYSE: HIMS)…

Hims & Hers Health, Inc. (HIMS) Shares Crash After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy, Faces Investor Scrutiny- Hagens Berman

/PRNewswire/ -- On June 23, 2025 investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their…

Hims & Hers Health CEO says compounding Novo weight-loss drug will continue

Hims & Hers Health CEO Andrew Dudum said that the telehealth platform will continue to sell a compounded version of…

Hims & Hers CEO hits Novo Nordisk after breakup over knockoff Wegovy

CEO Andrew Dudum said Novo Nordisk had been pushing Hims & Hers to favor Wegovy over its own compounded weight…

Hims Wont Back Down From Selling Cheap Weight-Loss Shots

Hims & Hers Health CEO Andrew Dudum said the company will continue to sell cheap weight-loss shots despite Novo Nordisk…

Novo Nordisk split puts Hims & Hers future in question

Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the companys potential to…

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…

Hims & Hers Stock: Panic Sell Or Opportunistic Buy? (NYSE:HIMS)

The breakup between Hims & Hers and Novo Nordisk has hit HIMS stock hard with a 35% crash. Click here…

Hims & Hers Health Aktie: Rechtsstreit mit Novo Nordisk bedroht Vertrauen

Charlotte, NC (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von Truist: Die Analysten von Truist stufen die Aktie von Hims & Hers…

HIMS & HERS HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims on Behalf of Investors of Hims & Hers Health, Inc.

NEW YORK and NEW ORLEANS, June 24, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C.…

SHAREHOLDER ALERT: Hims & Hers Health, Inc. Sued For Securities Fraud by Block & Leviton LLP; August 25 Deadline To Seek To Serve As Lead Plaintiff

Block & Leviton LLP filed a class action lawsuit today against Hims & Hers Health Inc. (NYSE: HIMS). Investors should…

dpa-AFX ProFeed